|
1
|
Sarfati D, Koczwara B and Jackson C: The
impact of comorbidity on cancer and its treatment. CA Cancer J
Clin. 66:337–350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gurney J, Sarfati D and Stanley J: The
impact of patient comorbidity on cancer stage at diagnosis. Br J
Cancer. 113:1375–1380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee L, Cheung WY, Atkinson E and
Krzyzanowska MK: Impact of comorbidity on chemotherapy use and
outcomes in solid tumors: A systematic review. J Clin Oncol.
29:106–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janssen-Heijnen ML, Houterman S, Lemmens
VE, Louwman MW, Maas HA and Coebergh JW: Prognostic impact of
increasing age and co-morbidity in cancer patients: A
population-based approach. Crit Rev Oncol Hematol. 55:231–240.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van de Poll-Franse LV, Houterman S,
Janssen-Heijnen ML, Dercksen MW, Coebergh JW and Haak HR: Less
aggressive treatment and worse overall survival in cancer patients
with diabetes: A large population based analysis. Int J Cancer.
120:1986–1992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon SJ, Kim EJ, Seo HJ and Oh IH: The
association between Charlson comorbidity index and the medical care
cost of cancer: A retrospective study. Biomed Res Int.
2015:2593412015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Søgaard M, Thomsen RW, Bossen KS, Sørensen
HT and Nørgaard M: The impact of comorbidity on cancer survival: A
review. Clin Epidemiol. 5 (Suppl 1):S3–S29. 2013. View Article : Google Scholar
|
|
8
|
Tammemagi CM, Neslund-Dudas C, Simoff M
and Kvale P: Impact of comorbidity on lung cancer survival. Int J
Cancer. 103:792–802. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piccirillo JF: Importance of comorbidity
in head and neck cancer. Laryngoscope. 110:593–602. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Houterman S, Janssen-Heijnen ML, Verheij
CD, Louwman WJ, Vreugdenhil G, Van Der Sangen MJ and Coebergh JW:
Comorbidity has negligible impact on treatment and complications
but influences survival in breast cancer patients. Br J Cancer.
90:2332–2337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dominick K, Bosworth H and Dudley T:
Comparison of three comorbidity indices for prediction of health
service use. Gerontologist 44: 120-; 2004
|
|
12
|
Stavrou EP, Lu CY, Buckley N and Pearson
S: The role of comorbidities on the uptake of systemic treatment
and 3-year survival in older cancer patients. Ann Oncol.
23:2422–2428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vissers PA, Thong MS, Pouwer F, Zanders
MM, Coebergh JW and van de Poll-Franse LV: The impact of
comorbidity on health-related quality of life among cancer
survivors: Analyses of data from the PROFILES registry. J Cancer
Surviv. 7:602–613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yun YH, Kim SH, Lee KM, Park SM and Kim
YM: Age, sex, and comorbidities were considered in comparing
reference data for health-related quality of life in the general
and cancer populations. J Clin Epidemiol. 60:1164–1175. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smith AW, Reeve BB, Bellizzi KM, Harlan
LC, Klabunde CN, Amsellem M, Bierman AS and Hays RD: Cancer,
comorbidities, and health-related quality of life of older adults.
Health Care Financ Rev. 29:41–56. 2008.PubMed/NCBI
|
|
16
|
Piccirillo JF, Vlahiotis A, Barrett LB,
Flood KL, Spitznagel EL and Steyerberg EW: The changing prevalence
of comorbidity across the age spectrum. Crit Rev Oncol Hematol.
67:124–132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stenholm S, Westerlund H, Head J, Hyde M,
Kawachi I, Pentti J, Kivimäki M and Vahtera J: Comorbidity and
functional trajectories from midlife to old age: The health and
retirement study. J Gerontol A Biol Sci Med Sci. 70:332–338. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Extermann M: Measuring comorbidity in
older cancer patients. Eur J Cancer. 36:453–41. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarfati D: Review of methods used to
measure comorbidity in cancer populations: No gold standard exists.
J Clin Epidemiol. 65:924–933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Connolly KL, Jeong JM, Barker CA,
Hernandez M and Lee EH: A systematic review of comorbidity indices
used in the nonmelanoma skin cancer population. J Am Acad Dermatol.
76:344–346.e2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Groot V, Beckerman H, Lankhorst GJ and
Bouter LM: How to measure comorbidity: A critical review of
available methods. J Clin Epidemiol. 56:221–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hall SF: A user's guide to selecting a
comorbidity index for clinical research. J Clin Epidemiol.
59:849–855. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wass M, Hitz F, Schaffrath J, Müller-Tidow
C and Müller LP: Value of different comorbidity indices for
predicting outcome in patients with acute myeloid leukemia. PLoS
One. 11:e01645872016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nesic VS, Petrovic ZM, Sipetic SB, Jesic
SD, Soldatovic IA and Kastratovic DA: Comparison of the adult
comorbidity evaluation 27 and the Charlson comorbidity indices in
patients with laryngeal squamous cell carcinoma. J Laryngol Otol.
126:516–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nitz NM: Comorbidity. Understanding health
care outcomes research. Kane R: Aspen Publishing Inc.;
Gaithersburg, MD: pp. 153–174. 1997
|
|
26
|
Yurkovich M, Avina-Zubieta JA, Thomas J,
Gorenchtein M and Lacaille D: A systematic review identifies valid
comorbidity indices derived from administrative health data. J Clin
Epidemiol. 68:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Page MJ, Moher D, Bossuyt PM, Boutron I,
Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: PRISMA 2020 explanation and elaboration: Updated
guidance and exemplars for reporting systematic reviews. BMJ.
372:n1602021. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Piccirillo JF, Tierney RM, Costas I, Grove
L and Spitznagel JE Jr: Prognostic importance of comorbidity in a
hospital-based cancer registry. JAMA. 291:2441–2447. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Austin PC, Shah BR, Newman A and Anderson
GM: Using the Johns Hopkins' aggregated diagnosis groups (ADGs) to
predict 1-year mortality in population-based cohorts of patients
with diabetes in Ontario, Canada. Diabet Med. 29:1134–1141. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sarfati D, Gurney J, Stanley J, Salmond C,
Crampton P, Dennett E, Koea J and Pearce N: Cancer-specific
administrative data-based comorbidity indices provided valid
alternative to Charlson and national cancer institute indices. J
Clin Epidemiol. 67:586–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Charlson ME, Pompei P, Ales KL and
MacKenzie CR: A new method of classifying prognostic comorbidity in
longitudinal studies: Development and validation. J Chronic Dis.
40:373–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Charlson M, Szatrowski TP, Peterson J and
Gold J: Validation of a combined comorbidity index. J Clin
Epidemiol. 47:1245–1251. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deyo RA, Cherkin DC and Ciol MA: Adapting
a clinical comorbidity index for use with ICD-9-CM administrative
databases. J Clin Epidemiol. 45:613–619. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bøje CR, Dalton SO, Primdahl H, Kristensen
CA, Andersen E, Johansen J, Andersen LJ and Overgaard J: Evaluation
of comorbidity in 9388 head and neck cancer patients: A national
cohort study from the DAHANCA database. Radiother Oncol. 110:91–97.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Romano PS, Roos LL and Jollis JG: Adapting
a clinical comorbidity index for use with ICD-9-CM administrative
data: Differing perspectives. J Clin Epidemiol. 46:1075–1079.
1081–1090. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Elixhauser A, Steiner C, Harris DR and
Coffey RM: Comorbidity measures for use with administrative data.
Med Care. 36:8–27. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Klabunde CN, Potosky AL, Legler JM and
Warren JL: Development of a comorbidity index using physician
claims data. J Clin Epidemiol. 53:1258–1267. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Klabunde CN, Legler JM, Warren JL, Baldwin
LM and Schrag D: A refined comorbidity measurement algorithm for
claims-based studies of breast, prostate, colorectal, and lung
cancer patients. Ann Epidemiol. 17:584–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noer MC, Sperling CD, Antonsen SL, Ottesen
B, Christensen IJ and Høgdall C: A new clinically applicable
age-specific comorbidity index for preoperative risk assessment of
ovarian cancer patients. Gynecol Oncol. 141:471–478. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sloan KL, Sales AE, Liu CF, Fishman P,
Nichol P, Suzuki NT and Sharp ND: Construction and characteristics
of the RxRisk-V: A VA-adapted pharmacy-based case-mix instrument.
Med Care. 41:761–774. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Colinet B, Jacot W, Bertrand D, Lacombe S,
Bozonnat MC, Daures JP and Pujol JL; oncoLR health network, : A new
simplified comorbidity score as a prognostic factor in
non-small-cell lung cancer patients: Description and comparison
with the Charlson's index. Br J Cancer. 93:1098–1105. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dobbins TA, Badgery-Parker T, Currow DC
and Young JM: Assessing measures of comorbidity and functional
status for risk adjustment to compare hospital performance for
colorectal cancer surgery: A retrospective data-linkage study. BMC
Med Inform Decis Mak. 15:552015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Genther DJ and Gourin CG: Effect of
comorbidity on short-term outcomes and cost of care after head and
neck cancer surgery in the elderly. Head Neck. 37:685–693. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hsieh MC, Thompson T, Wu XC, Styles T,
O'Flarity MB, Morris CR and Chen VW: The effect of comorbidity on
the use of adjuvant chemotherapy and type of regimen for curatively
resected stage III colon cancer patients. Cancer Med. 5:871–880.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Islam KM, Jiang X, Anggondowati T, Lin G
and Ganti AK: Comorbidity and survival in lung cancer patients.
Cancer Epidemiol Biomarkers Prev. 24:1079–1085. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kuwada K, Kuroda S, Kikuchi S, Yoshida R,
Nishizaki M, Kagawa S and Fujiwara T: Sarcopenia and comorbidity in
gastric cancer surgery as a useful combined factor to predict
eventual death from other causes. Ann Surg Oncol. 25:1160–1166.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin J, McGlynn KA, Nations JA, Shriver CD
and Zhu K: Comorbidity and stage at diagnosis among lung cancer
patients in the US military health system. Cancer Causes Control.
31:255–261. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
van Eeghen EE, Bakker SD, van Bochove A
and Loffeld RJ: Impact of age and comorbidity on survival in
colorectal cancer. J Gastrointest Oncol. 6:605–612. 2015.PubMed/NCBI
|
|
49
|
Ahern TP, Horváth-Puhó E, Spindler KL,
Sørensen HT, Ording AG and Erichsen R: Colorectal cancer,
comorbidity, and risk of venous thromboembolism: Assessment of
biological interactions in a Danish nationwide cohort. Br J Cancer.
114:96–102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Belot A, Fowler H, Njagi EN,
Luque-Fernandez MA, Maringe C, Magadi W, Exarchakou A, Quaresma M,
Turculet A, Peake MD, et al: Association between age, deprivation
and specific comorbid conditions and the receipt of major surgery
in patients with non-small cell lung cancer in England: A
population-based study. Thorax. 74:51–59. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cao KI, Salviat F, Laki F, Falcou MC,
Carton M, Poortmans P, Fourquet A and Kirova YM: Outcomes of
postoperative radiation therapy for breast cancer in older women
according to age and comorbidity status: An observational
retrospective study in 752 patients. J Geriatr Oncol. 9:600–605.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cao KI, Waechter L, Carton M and Kirova
YM: Outcomes of exclusive radiation therapy for older women with
breast cancer according to age and comorbidity status: An
observational retrospective study. Breast J. 26:976–980. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Murawski M, Walter J and Schwarzkopf L:
Assessing the lung cancer comorbidome: An analysis of German claims
data. Lung Cancer. 127:122–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Niazi SK, Naessens JM, White L, Borah B,
Vargas ER, Richards J, Cabral S, Clark MM and Rummans T: Impact of
psychiatric comorbidities on health care costs among patients with
cancer. Psychosomatics. 61:145–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mohammadi M, Cao Y, Glimelius I, Bottai M,
Eloranta S and Smedby KE: The impact of comorbid disease history on
all-cause and cancer-specific mortality in myeloid leukemia and
myeloma-a Swedish population-based study. BMC Cancer. 15:8502015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sarfati D, Gurney J, Lim BT, Bagheri N,
Simpson A, Koea J and Dennett E: Identifying important comorbidity
among cancer populations using administrative data: Prevalence and
impact on survival. Asia Pac J Clin Oncol. 12:e47–e56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Stordeur S, Schillemans V, Savoye I,
Vanschoenbeek K, Leroy R, Macq G, Verleye L, De Gendt C, Nuyts S,
Vermorken J, et al: Comorbidity in head and neck cancer: Is it
associated with therapeutic delay, post-treatment mortality and
survival in a population-based study? Oral Oncol. 102:1045612020.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Aarts MJ, Aerts JG, van den Borne BE,
Biesma B, Lemmens VE and Kloover JS: Comorbidity in patients with
small-cell lung cancer: Trends and prognostic impact. Clin Lung
Cancer. 16:282–291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Manderbacka K, Arffman M, Suvisaari J,
Ahlgren-Rimpiläinen A, Lumme S, Keskimäki I and Pukkala E: Effect
of stage, comorbidities and treatment on survival among cancer
patients with or without mental illness. Br J Psychiatry.
211:304–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Noer MC, Leandersson P, Paulsen T, Rosthøj
S, Antonsen SL, Borgfeldt C and Høgdall C: Confounders other than
comorbidity explain survival differences in Danish and Swedish
ovarian cancer patients-a comparative cohort study. Acta Oncol.
57:1100–1108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Noer MC, Sperling CD, Ottesen B, Antonsen
SL, Christensen IJ and Høgdall C: Ovarian cancer and comorbidity:
Is poor survival explained by choice of primary treatment or system
delay? Int J Gynecol Cancer. 27:1123–1133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Skyrud KD, Bray F, Eriksen MT, Nilssen Y
and Møller B: Regional variations in cancer survival: Impact of
tumour stage, socioeconomic status, comorbidity and type of
treatment in Norway. Int J Cancer. 138:2190–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Drzayich Antol D, Waldman Casebeer A,
Khoury R, Michael T, Renda A, Hopson S, Parikh A, Stein A,
Costantino M, Stemkowski S and Bunce M: The relationship between
comorbidity medication adherence and health related quality of life
among patients with cancer. J Patient Rep Outcomes. 2:292018.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Efird JT, Hunter S, Chan S, Jeong S,
Thomas SL, Jindal C and Biswas T: The association between age,
comorbidities and use of radiotherapy in women with breast cancer:
Implications for survival. Medicines (Basel). 5:622018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Binder PS, Peipert JF, Kallogjeri D,
Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH and McCourt
CK: Adult comorbidity evaluation 27 score as a predictor of
survival in endometrial cancer patients. Am J Obstet Gynecol.
215:766.e1–766.e9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
DeWees TA, Nikitas J, Rehman S, Bradley
JD, Robinson CG and Roach MC: Defining optimal comorbidity measures
for patients with early-stage non-small cell lung cancer treated
with stereotactic body radiation therapy. Pract Radiat Oncol.
9:e83–e89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Göllnitz I, Inhestern J, Wendt TG,
Buentzel J, Esser D, Böger D, Mueller AH, Piesold JU,
Schultze-Mosgau S, Eigendorff E, et al: Role of comorbidity on
outcome of head and neck cancer: A population-based study in
Thuringia, Germany. Cancer Med. 5:3260–3271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zist A, Amir E, Ocana AF and Seruga B:
Impact of comorbidity on the outcome in men with advanced prostate
cancer treated with docetaxel. Radiol Oncol. 49:402–408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Quan H, Li B, Couris CM, Fushimi K, Graham
P, Hider P, Januel JM and Sundararajan V: Updating and validating
the Charlson comorbidity index and score for risk adjustment in
hospital discharge abstracts using data from 6 countries. Am J
Epidemiol. 173:676–682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Grønhøj C, Kronberg Jakobsen K, Kjær E,
Friborg J and von Buchwald C: Comorbidity in HPV+ and HPV-
oropharyngeal cancer patients: A population-based, case-control
study. Oral Oncol. 96:1–6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Marventano S, Grosso G, Mistretta A,
Bogusz-Czerniewicz M, Ferranti R, Nolfo F, Giorgianni G, Rametta S,
Drago F, Basile F and Biondi A: Evaluation of four comorbidity
indices and Charlson comorbidity index adjustment for colorectal
cancer patients. Int J Colorectal Dis. 29:1159–1169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gluckman TJ, Spinelli KJ, Wang M, Yazdani
A, Grunkemeier G, Bradley SM, Wasfy JH, Goyal A, Oseran A and Joynt
Maddox KE: Trends in diagnosis related groups for inpatient
admissions and associated changes in payment from 2012 to 2016.
JAMA Netw Open. 3:e20284702020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lüchtenborg M, Morris EJA, Tataru D,
Coupland VH, Smith A, Milne RL, Te Marvelde L, Baker D, Young J,
Turner D, et al: Investigation of the international comparability
of population-based routine hospital data set derived comorbidity
scores for patients with lung cancer. Thorax. 73:339–349. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wong RJ, Chou C, Sinha SR, Kamal A and
Ahmed A: Ethnic disparities in the association of body mass index
with the risk of hypertension and diabetes. J Community Health.
39:437–445. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
National Cancer Intelligence Network
(NCIN), . Cancer Incidence and Survival By Major Ethnic Group,
England, 2002–2006. NCIN; London: 2009, https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwin7Zbruu7vAhWOURUIHTVrAgwQFjABegQIAxAD&url=http%3A%2F%2Fwww.ncin.org.uk%2Fview%3Frid%3D75&usg=AOvVaw3z7JFntDtb9_kGh3CDWurO
|
|
76
|
Hwang SW, Chambers C, Chiu S, Katic M,
Kiss A, Redelmeier DA and Levinson W: A comprehensive assessment of
health care utilization among homeless adults under a system of
universal health insurance. Am J Public Health. 103 (Suppl
2):S294–S301. 2013. View Article : Google Scholar : PubMed/NCBI
|
